PT  - JOURNAL ARTICLE
AU  - F. Stain-Texier
AU  - P. Sandouk
AU  - J-M. Scherrmann
TI  - Intestinal Absorption and Stability of Morphine 6-Glucuronide in Different Physiological Compartments of the Rat
DP  - 1998 May 01
TA  - Drug Metabolism and Disposition
PG  - 383--387
VI  - 26
IP  - 5
4099  - http://dmd.aspetjournals.org/content/26/5/383.short
4100  - http://dmd.aspetjournals.org/content/26/5/383.full
SO  - Drug Metab Dispos1998 May 01; 26
AB  - Morphine 6-glucuronide (M6G) is an active metabolite of morphine that could be used as a drug, but its hydrolysis into morphine remains controversial. We investigated the acidic hydrolysis of M6G and found that the recovery of morphine did not exceed 5%. The stability of M6G was studied in different physiological compartments of male Sprague-Dawley rats. The formation of morphine after M6G incubation in feces was under 2% in the small intestine, whereas the formation of morphine in colon feces represented 85.6 ± 12.9% of the initial concentration of M6G. The stability of M6G was also determined ex vivo using the isolated perfused rat liver. The hepatic extraction ratio of M6G was very low (0.04 ± 0.02), but 88.7 ± 11.2% of the dose was excreted in bile. The elimination half-life of M6G in the perfusate (66.4 ± 20.6 min) was higher than the elimination half-life in bile (18.6 ± 2.5 min). The hydrolysis of M6G was low, with only 7.7% and 0.03% of morphine in the perfusate and bile, respectively. The perfusate level of morphine 3-glucuronide (M3G) resulting from morphine conjugation was 4.9 ± 3.6%. Anin vivo experiment demonstrated that after oral administration, M6G was absorbed per se in the proximal intestine, and the process was prolonged over the 24-hr experiment due to its reabsorption following enterohepatic recirculation. Finally, 10.5 ± 4.3% of morphine and 12.9 ± 5.1% of M3G compared with M6G AUCs were found in plasma. These results show that M6G is weakly converted into morphine when orally absorbed, with a kinetic profile similar to a slow release formulation. The American Society for Pharmacology and Experimental Therapeutics